Walleye Trading
LRMR icon

Walleye Trading’s Larimar Therapeutics LRMR Stock Holding History

Walleye Trading’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61K Hold
20,000
– – ﹤0.01% 3542
2026
Q1 		$90K Sell
20,000
-5,000
-20% -$20K ﹤0.01% 3495
2025
Q4 		$95.3K Hold
25,000
– – ﹤0.01% 3761
2025
Q3 		$80.8K Hold
25,000
– – ﹤0.01% 3809
2025
Q2 		$72.3K Hold
25,000
– – ﹤0.01% 3711
2025
Q1 		$53.8K Hold
25,000
– – ﹤0.01% 3590
2024
Q4 		$96.8K Buy
+25,000
New +$165K ﹤0.01% 3561

Other funds holding LRMR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
NLP
Next Level Private Harrison, New York $511M AUM 30.94% 1-Year Est. Return

Walleye Trading's LRMR Position: Q2 2026 in Review

Walleye Trading held its Larimar Therapeutics (LRMR) position steady in Q2 2026 at 20,000 shares worth $61K. The position accounts for ﹤0.01% of the portfolio, ranked #3542.

Walleye Trading first reported a position in LRMR in Q4 2024 and has held it in 7 quarters since. The position peaked at $96.8K in Q4 2024. 49 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Walleye Trading held 20,000 shares of Larimar Therapeutics worth $61K as of Q2 2026.
  • Walleye Trading left its Larimar Therapeutics share count unchanged in Q2 2026.
  • Larimar Therapeutics made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #3542 holding.
  • Walleye Trading first reported a position in Larimar Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Walleye Trading's Larimar Therapeutics position peaked at $96.8K in Q4 2024.
  • 49 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.